Loading...
Loading...
Bank of America reiterated its Neutral rating on LifePoint Hospitals
LPNT and reduced its price objective from $46 to $43.
Bank of America commented, "Q3 was disappointing on a number of fronts and even adjusting for all the items LPNT claims as 1x, normalized EBITDA was 11% below consensus, with guidance implying a similar reduction in Q4. … With no formal guidance from the company yet, we estimate 2013 EBITDA could be $572-$602m, up 7-11% y/y. After analyzing the puts and takes, we feel comfortable above the midpoint of that range, but it still marks a reduction vs. our prior est of $636m and our visibility in LPNT's operations is clearly lower after this quarter. We are reducing our 2012/13/14 EPS ests to $3.14/$3.51/$4.42 from $3.59/$3.77/$4.54 and cutting our PO to $43 from $46."
LifePoint Hospitals closed at $36,16 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: Analyst ColorPrice TargetReiterationIntraday UpdateAnalyst RatingsBank of AmericaHealth CareHealth Care Facilities
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in